QUERZOLI, Patrizia
 Distribuzione geografica
Continente #
NA - Nord America 8.668
AS - Asia 4.173
EU - Europa 3.483
SA - Sud America 721
AF - Africa 77
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 4
Totale 17.133
Nazione #
US - Stati Uniti d'America 8.446
SG - Singapore 1.710
CN - Cina 1.284
IT - Italia 1.087
BR - Brasile 611
DE - Germania 599
UA - Ucraina 461
GB - Regno Unito 326
HK - Hong Kong 317
TR - Turchia 302
VN - Vietnam 246
PL - Polonia 202
FI - Finlandia 191
SE - Svezia 188
RU - Federazione Russa 128
CA - Canada 118
MX - Messico 90
IN - India 77
FR - Francia 73
ID - Indonesia 61
BE - Belgio 57
NL - Olanda 44
ZA - Sudafrica 44
BD - Bangladesh 38
JP - Giappone 37
AR - Argentina 36
ES - Italia 26
CZ - Repubblica Ceca 22
AT - Austria 20
EC - Ecuador 20
LT - Lituania 20
IQ - Iraq 15
CO - Colombia 14
UZ - Uzbekistan 13
MA - Marocco 12
VE - Venezuela 10
KE - Kenya 9
PK - Pakistan 9
PY - Paraguay 9
RO - Romania 9
CL - Cile 7
IR - Iran 7
KZ - Kazakistan 6
UY - Uruguay 6
BO - Bolivia 5
AE - Emirati Arabi Uniti 4
EU - Europa 4
IE - Irlanda 4
IL - Israele 4
JM - Giamaica 4
JO - Giordania 4
MD - Moldavia 4
MY - Malesia 4
NP - Nepal 4
SA - Arabia Saudita 4
AL - Albania 3
AU - Australia 3
AZ - Azerbaigian 3
BH - Bahrain 3
CH - Svizzera 3
CR - Costa Rica 3
HU - Ungheria 3
NZ - Nuova Zelanda 3
PE - Perù 3
SK - Slovacchia (Repubblica Slovacca) 3
DO - Repubblica Dominicana 2
DZ - Algeria 2
EG - Egitto 2
GE - Georgia 2
HN - Honduras 2
KR - Corea 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
OM - Oman 2
PH - Filippine 2
PS - Palestinian Territory 2
TN - Tunisia 2
AG - Antigua e Barbuda 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
DK - Danimarca 1
ET - Etiopia 1
GD - Grenada 1
GR - Grecia 1
KH - Cambogia 1
KW - Kuwait 1
LB - Libano 1
LU - Lussemburgo 1
LY - Libia 1
MU - Mauritius 1
NO - Norvegia 1
PT - Portogallo 1
RS - Serbia 1
SD - Sudan 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TJ - Tagikistan 1
TL - Timor Orientale 1
Totale 17.129
Città #
Singapore 970
Ashburn 894
Woodbridge 782
Chandler 607
Fairfield 593
Ann Arbor 537
Jacksonville 496
Santa Clara 443
Beijing 405
Houston 391
Hong Kong 317
Wilmington 266
Seattle 252
New York 211
Warsaw 196
Izmir 194
Cambridge 193
Dallas 178
Los Angeles 175
Munich 168
Nanjing 159
Princeton 112
Milan 98
Ferrara 88
Buffalo 86
Ho Chi Minh City 83
Shanghai 82
Boardman 77
Nanchang 70
Turku 70
Bremen 68
Mexico City 61
Dearborn 60
São Paulo 60
San Diego 58
Brooklyn 57
Brussels 56
Hanoi 50
Jakarta 49
Rome 47
Tianjin 46
Shenyang 44
Montreal 43
Hebei 41
Denver 36
Falls Church 36
Tokyo 34
Chicago 33
Orem 33
Changsha 32
Chennai 31
Hefei 30
London 30
Stockholm 30
Atlanta 29
Johannesburg 29
Toronto 29
Helsinki 28
Falkenstein 27
The Dalles 27
Poplar 25
Bologna 24
Boston 24
San Mateo 24
Zhengzhou 24
Jiaxing 23
Redwood City 23
Jinan 22
San Jose 22
Auburn Hills 21
Frankfurt am Main 21
Manchester 21
Moscow 21
Phoenix 21
Guangzhou 20
San Francisco 20
Rio de Janeiro 18
Nuremberg 17
Haiphong 16
Norwalk 16
Belo Horizonte 15
Philadelphia 15
Querétaro 15
Mountain View 14
Addison 13
Amsterdam 13
Ankara 13
Brasília 13
Brno 13
Council Bluffs 13
New Delhi 13
Ottawa 13
Vienna 13
Da Nang 12
Verona 12
Hangzhou 11
Orange 11
Tashkent 11
Campinas 10
Charlotte 10
Totale 11.103
Nome #
Applicazione della tecnica di metilazione specifica PCR (MSP) con un pannel di quattro markers su campioni citologici di patologia mammaria. 626
Integrazione del Nottingham Prognostic Index con i fenotipi biologici per una migliore definizione prognostica delle pazienti affette da carcinoma della mammella. 464
Diagnostic and prognostic microRNAs in the serum of breast cancer patients measured by droplet digital PCR 256
High-sensitivity assay for monitoring ESR1 mutations in circulating cell-free DNA of breast cancer patients receiving endocrine therapy 255
Breast Cancer and Simian Virus 40 Infection 225
Caratterizzazione biopatologica del carcinoma mammario: standardizzazione immunoistochimica 224
Primary breast cancer features can predict additional lymph node involvement in patients with sentinel node micrometastases 224
Phospholipase C-beta2 promotes mitosis and migration of human breast cancer-derived cells 221
MicroRNA profiling for the identification of cancers with unknown primary tissue-of-origin 219
CD8+ T cells expressing IL-10 are associated with a favourable prognosis in lung cancer 213
Polycystin-1 regulates amphiregulin expression through CREB and AP1 signalling: implications in ADPKD cell proliferation 207
miR-125b targets erythropoietin and its receptor and their expression correlates with metastatic potential and ERBB2/HER2 expression 204
CD8 + ve cell infiltration correlates with angiogenesis in non-small cell lung cancer (NSCLC) of patients with chronic obstructive pulmonary disease 195
Valutazione dell'espressione di GATA3 con tecnica del tissue microarray (TMA) e significato prognostico nel carcinoma mammario infiltrante 194
Espressione dell'oncoproteina virale antigene T-grande di SV40 in carcinomi mammari infiltranti valutata su Tissue micro arrays (TMAs) 192
miR-501 overexpression in renal carcinomas 190
Application of quantitative analysis to biologic profile evaluation in breast cancer 186
HER2-Positive Lobular Versus Ductal Carcinoma of the Breast: Pattern of First Recurrence and Molecular Insights 184
Clinical usefulness of estrogen receptor immunocytochemistry in human breast cancer 182
Biology, prognosis and response to therapy of breast carcinomas according to HER2 score 181
Sentinel node study in early breast cancer 181
Serologic investigation on undifferentiated nasopharyngeal carcinoma and Simian Virus 40 infection 180
Decreased heme-oxygenase (HO)-1 in the macrophages of non-small cell lung cancer 176
Valutazione biologica multiparametrica di 5284 carcinomi mammari infiltranti (1990-2005): il ruolo del patologo nelle scelte terapeutiche 175
Axyllary lymph node nanometastases are prognostic factors for disease-free survival and metastatic relapse in breast cancer patiensts 175
Prognostic and therapeutic impact of sentinel node micrometastasis in patients with invasive breast cancer 174
Core needle biopsy in invasive breast cancer prognostic/predictive power: concordance with surgical speciemen and impact of immunophenotypes 173
Factors responsible of scintigraphic false-negative sentinel lymph node detection in brest cancer 172
The 70 Gene Mammaprint signature: Ferrara's experience 171
Espressione dei MicroRNA nei carcinomi mammari 166
Tumour-infiltrating CD8+ cells expressing IL-10, but not CD8+, CD4+ and CD68+ cells, are associated with a better prognosis in patients with NSCLC 162
Macrophage expression of interleukin-10 is a prognostic factor in nonsmall cell lung cancer 161
Clinical-diagnostic meaning of mammary uptake accidentally detected during 18F-FDG PET/CT (PET): comparison between radiological imaging and histopathology. 161
Il protocollo Diagnostico-Terapeutico e Assistenziale per il carcinoma mammario della Regione Emilia-Romagna. I edizione 160
An international study comparing conventional versus mRNA level testing (TargetPrint) for ER, PR, and HER2 status of breast cancer 159
PLC-β2 is highly expressed in breast cancer and is associated with a poor outcome: A study on tissue microarrays 158
Pathophysiology of estrogen receptors in mammary tissue by monoclonal antibodies 158
Prognostic and predictive factors related to metastatic breast cancer clinical history: an outcome study [Fattori prognostici e predittivi nella storia clinica del carcinoma metastatico della mammella: Uno studio di esito] 157
Contribution of cell kinetics with Ki-67 to the biopathological and prognostic characterization of breast cancer 156
Tumour infiltrating lymphocytes and tumour associated macrophages in chronic obstructive pulmonary disease (COPD) patients with non-small cell lung cancer (NSCLC) and in patients with NSCLC 154
Quantitative immunoprofiles of breast cancer performed by image analysis 154
Expression of IL-10 by CD8+ T Cells Is a Favorable Prognostic Factor in Non-Small Cell Lung Cancer 154
Biology and prognosis of 1685 recently diagnosed HER2 positive breast carcinomas 153
Modulation of biomarkers in minimal breast carcinoma: A model for human breast carcinoma progression 150
BRCA1 LOH and biological profile of breast cancer. Comparison between two age groups. 150
Oncogenic role of miR-483-3p at the IGF2/483 locus 149
Loss of methylation at chromosome 11p15.5 is common in human adult tumors 148
Biological profile of breast carcinoma in situ investigated by immunohistochemical technique 147
Commentary on human mammary neoplasia. The Estrogen Receptor-promotion hypothesis 144
Mib-1 proliferative activity in invasive breast cancer measured by image analysis 144
Comparison of cytology test in patients under surveillance after transurethral resection of superficial urothelial carcinoma 144
Indicatori e valori di riferimento nella valutazione della ploidia del carcinoma mammario 143
Quality control for biomarker determination in oncology: The experience of the Italian Network for Quality Assessment of Tumor Biomarkers (INQAT) 143
A case of invasive solid papillary breast carcinoma resembling tall cell variant of papillary thyroid carcinoma 143
Estrogen receptor mutation: a new strategy to overcome endocrine resistance 142
Positive predictive value for malignancy on surgical excision of breast lesions of uncertain malignant potential (B3) diagnosed by stereotactic vacuum-assisted needle core biopsy (VANCB): a large multi-insitutional study in Italy 142
Increased overall survival independent of RECIST response in metastatic breast cancer patients continuing trastuzumab treatment: Evidence from a retrospective study 141
Increased neurokinin-2 receptor expression in alveolar macrophages of smokers with COPD 140
The 70 gene Mammaprint Signature: a comparison with traditional clinco-pathological tools. 140
Axillary lymph node nanometastases are prognostic factors for metastatic relapse 140
Biological tissue characterisation in narrow beam x-ray scattering techniques 139
Increased of A3 adenosine receptors by depleted expression of polycystic kidney disease-1 gene (PKD1) in human renal cell and tissues: implication for cAMP-dependent signalling and proliferation of PKD1-mutated cystic cells 138
An original approach in the diagnosis of early breast cancer: use of the same radipharmaceutical for both non palpable lesions and sentinel node localization 138
Expression of p21 ras gene products in breast cancer relates to histological types and to receptor nodal status 137
Cytoplasmic Trop-1/Ep-CAM Overexpression is Associated with a Favorable Outcome in Node-positive Breast Cancer 136
Interleukin (IL)-10 expression in non-small cell lung cancer is associated with cigarette smoking 136
Prevalence of post-stress myocardial stunning by gated-SPECT in diabetic patients: results of a prospective, multi-center trial 134
Role of the miR-501 in Renal Carcinomas 134
High expression of 90K (Mac-2 BP) is associated with poor survival in node-negative breast cancer patients not receiving adjuvant systemic therapies 131
Observational DEMETRA STUDY: survival of metastatic breast carcinoma patients after treatment with Trastuzumab 131
Treatment of a relapsing facial pyoderma gangrenosum (malignant pyoderma) 131
Immunocytochemical Demonstration of Estrogen Receptors by Monoclonal antibodies in Human breast cancer: Correlation with estrogen receptor assay by Dextran-coated Charcoal Method 130
Lymph node micrometastases do influence breast cancer outcome 130
An immunohistochemically positive E-cadherin status is not always predictive for a good prognosis in human breast cancer 129
Differential expression of heme oxygenase (HO)-1 in macrophages of lung tumour and tumour-free lung tissues 126
Interobserver reproducibility of immunohistochemical HER-2/neu assessment in human breast cancer: An update from INQAT round III 125
Urovysion(TM) test: confronto tra citologia convenzionale e citologia molecolare nel follow-up di pazienti affetti da patologia neoplastica dell'urotelio 125
Morphological parameters of flat epithelial atypia (FEA) in stereotactic vacuum-assisted needle core biopsies do not predict the presence of malignancy on subsequent surgical excision 121
Sentinel node and bone marrow micro metastases and nanometastases 120
Tumor infiltrating lymphocytes in triple negative breast cancer and correlations with prognosis 117
Significant correlation between interleukin-10 expression and progression of non-small cell lung cancer through heme oxygenase 117
MicroRNAs: toward the clinic for breast cancer patients 115
p53 status identifies two subgroups of triple-negative breast cancers with distinct biological features 115
Interobserver reproducibility of immunohistochemical HER-2/neu evaluation in human breast cancer: The real-world experience 112
null 111
Pattern of distant recurrence according to the molecular subtypes identified by immunohistochemistry in women with early breast cancer 109
null 107
Biophenotypes and survival of BRCA1 and TP53 deleted breast cancer in young women 107
Biological staging of incipient, in situ and invasive breast carcinomas 101
null 101
Clinical and therapeutic importance of sentinel node biopsy of the internal mammary chain in patients with breast cancer: a single-center study with long-term follow-up. 99
The 70-Gene Mammaprint Signature for risk stratification in breast cancer: a comparison with traditional pathological and clinical tools 98
null 98
Fattori predittivi del rischio di ulteriore metastatizzazione linfonodale ascellare in pazienti con linfonodo sentinella micrometastatico da tumore della mammella in fase precoce 96
Tumor infiltrating lymphocyte (TIL) and CD8+ cells in TNBC: new prognostic markers 95
null 94
null 94
Assessment of Proliferative rate of breast cancer by Ki-67 Monoclonal Antibody 94
null 93
Biophenotypes of breast carcinoma in situ defined by image analysis of biological parameters 91
Totale 15.737
Categoria #
all - tutte 74.588
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 531
Totale 75.119


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021765 0 0 0 0 0 144 46 140 27 153 177 78
2021/20221.276 50 117 70 87 93 52 66 86 52 103 99 401
2022/20231.359 97 112 54 183 259 211 63 126 142 7 66 39
2023/2024724 68 63 45 21 56 165 30 52 8 17 28 171
2024/20252.996 89 84 223 84 372 278 83 153 508 313 446 363
2025/20264.564 807 302 689 1.039 1.241 486 0 0 0 0 0 0
Totale 17.275